Literature DB >> 19181916

Sublobar resection for lung cancer.

R Rami-Porta1, M Tsuboi.   

Abstract

Sublobar resection for small lung cancers has been debated frequently and is still a controversial issue. The only randomised trial comparing lobectomy with sublobar resections found a significantly higher recurrence rate for the latter, but failed to show significant differences in survival, although survival was better for the lobectomy group. One meta-analysis and several nonrandomised comparisons have confirmed these results. In general, lobectomy and sublobar resections have similar 5-yr survival rates. Local recurrence after wedge resection is higher than after segmentectomy. However, for patients aged >71 yrs, lobectomy and wedge resection are associated with similar survival. For tumours of </=2 cm, segmentectomy is equivalent to lobectomy, but survival after segmentectomy is worse if performed for larger tumours. For both segmentectomy and wedge resection, tumour margins should be >/=1 cm wide to avoid recurrence. For pure bronchioloalveolar carcinoma of </=2 cm, diagnosed intraoperatively with certainty, sublobar resection seems equivalent to lobectomy, and because there is no nodal involvement, systematic nodal dissection may not be necessary. In case of doubt, however, lobectomy with systematic nodal dissection will ensure complete resection and adequate staging. More randomised trials are needed to confirm all these issues.

Entities:  

Mesh:

Year:  2009        PMID: 19181916     DOI: 10.1183/09031936.00099808

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  31 in total

1.  Improving lung cancer outcomes by improving the quality of surgical care.

Authors:  Raymond U Osarogiagbon; Thomas A D'Amico
Journal:  Transl Lung Cancer Res       Date:  2015-08

2.  Predictors of pathological non-invasive lung cancer with pure-solid appearance on computed tomography to identify possible candidates for sublobar resection.

Authors:  Aritoshi Hattori; Tatsuo Maeyashiki; Takeshi Matsunaga; Kazuya Takamochi; Shiaki Oh; Kenji Suzuki
Journal:  Surg Today       Date:  2015-04-22       Impact factor: 2.549

3.  The lobar vs. sublobar "limited" resection respiratory function preservation debate: learning to speak the same language.

Authors:  Vasileios Kouritas; Richard Milton
Journal:  Ann Transl Med       Date:  2017-04

4.  How to deal with subcentimeter lung cancer: a moving target!

Authors:  Paul E Van Schil
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

Review 5.  Is limited pulmonary resection equivalent to lobectomy for surgical management of stage I non-small-cell lung cancer?

Authors:  Maya K De Zoysa; Dima Hamed; Tom Routledge; Marco Scarci
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-02-27

6.  The impact of tumor size on the association of the extent of lymph node resection and survival in clinical stage I non-small cell lung cancer.

Authors:  Brian C Gulack; Chi-Fu Jeffrey Yang; Paul J Speicher; James M Meza; Lin Gu; Xiaofei Wang; Thomas A D'Amico; Matthew G Hartwig; Mark F Berry
Journal:  Lung Cancer       Date:  2015-10-14       Impact factor: 5.705

7.  The oncological outcomes of segmentectomy in clinical-T1b lung adenocarcinoma with a solid-dominant appearance on thin-section computed tomography.

Authors:  Aritoshi Hattori; Takeshi Matsunaga; Kazuya Takamochi; Shiaki Oh; Kenji Suzuki
Journal:  Surg Today       Date:  2015-10-15       Impact factor: 2.549

Review 8.  Imaging techniques for minimally invasive thoracic surgery-Korea University Guro Hospital experiences.

Authors:  Kook Nam Han; Hyun Koo Kim
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

9.  Surgery for mediastinal lymph node and early stage lung cancer: individualized practice based on clinical database.

Authors:  Yi-Ting Yen; Yau-Lin Tseng
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

10.  Clarification of the resection line non-intubated segmentectomy using indocyanine green.

Authors:  Can Vladimir; Kala Zdenek; Frola Lukas; Hudacek Kamil; Kalis Vaclav; Kodytkova Alzbeta; Mitas Ladislav; Moravcik Petr; Rybnickova Sylva; Skrivanova Katerina; Spankova Marketa; Vach Robert; Horvath Teodor
Journal:  Ann Transl Med       Date:  2019-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.